KRAS and non-small cell lung carcinoma: In the cBioPortal for Cancer Genomics database, which includes data from eight NSCLC studies, variants of TP53 (62%), KRAS (21%), EGFR (11%), PIK3CA (8%), BRAF (6%), and PTEN (5%) were reported to be major genetic changes [28].